Clinical trials have shown that transcatheter aortic valve implantation for aortic stenosis compares favorably to surgical replacement in high-risk patients and is superior to medical therapy in those at prohibitive risk. There is uncertainty however on patterns and trends in transcatheter aortic valve implantation, especially focusing on Italy.
The RISPEVA study is a prospective Italian registry including 21 institutions. A total of 1157 patients have been enrolled since late 2012, and data collection includes several baseline, procedural, in-hospital, and follow-up details.
According to results of the study, the Italian uptake of TAVI is steady, with evident trends toward less invasive approaches and fitter patients.
- Giordano A, Corcione N, Biondi-Zoccai G, Berti S, Petronio AS, Pierli C, Presbitero P, Giudice P, Sardella G, Bartorelli AL, Bonmassari R, Indolfi C, Marchese A, Brscic E, Cremonesi A, Testa L, Brambilla N, Bedogni F. Patterns and trends of transcatheter aortic valve implantation in Italy: insights from RISPEVA. J Cardiovasc Med 2016 Nov 24. [Epub ahead of print] Go to PubMed